Moolmuang, B., & Ruchirawat, M. (2021). The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. J Pharm Pharmacol, 73(1), 40-51. doi:10.1093/jpp/rgaa050
Moolmuang, B., & Ruchirawat, M. (2021). The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. J Pharm Pharmacol, 73(1), 40-51. doi:10.1093/jpp/rgaa050
Related Posts
28 Dec 2007
IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Boobis AR, Doe JE, Heinrich-Hirsch B, Meek ME, Munn S, Ruchirawat M, Schlatter J, Seed J, Vickers C Crit Rev Toxicol38p87-96(2008)
View More
13 Feb 2023
A validated LC-MS/MS method for clinical pharmacokinetics and presumptive phase II metabolic pathways following oral administration of Andrographis paniculata extract. Songvut P, Pholphana N, Suriyo T, Rangkadilok N, Panomvana D, Puranajoti P, Satayavivad J. Sci Rep. 2023 Feb 13;13(1):2534.
View More
Recent Posts
10 Feb 2025
Evaluation of tomato brown rugose fruit virus as a microbial source tracking marker for human sewage in Thailand. Paisantham P, Theplhar S, Srathongneam T, Sresung M, Mongkolsuk S, Sirikanchana K*. Sci Total Environ. 2025;5(1):178419.
View More
